Inference in randomized trials with death and missingness

Biometrics

Volumn 73, Issue 2, 2017, Pages 431-440

  Wang, Chenguang ^a   Scharfstein, Daniel O ^b   Colantuoni, Elizabeth ^b   Girard, Timothy D ^c   Yan, Ying ^d  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Iselin ^*  (United States)

Author keywords

Composite endpoint; Death truncated data; Missing data; Sensitivity analysis

Indexed keywords

ANALYSIS STRATEGIES; CLINICAL TRIAL; COMPOSITE ENDPOINT; DEATH-TRUNCATED DATA; MISSING DATA; MISSING DATA IMPUTATIONS; NON SMALL CELL LUNG CANCER; RANDOMIZED TRIAL; TRUNCATED DATA;

SENSITIVITY ANALYSIS;

DATA ACQUISITION; DATA SET; SENSITIVITY ANALYSIS;

FEMALE; HUMAN; LUNG TUMOR; NON SMALL CELL LUNG CANCER; PREGNANCY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; PREGNANCY; PREMATURE BIRTH; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84995470837     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/biom.12594     Document Type: Article

References (36)

1. Birmingham, J., Rotnitzky, A., and Fitzmaurice, G. M. (2003). Pattern-mixture and selection models for analysing longitudinal data with monotone missing patterns. Journal of the Royal Statistical Society, Series B 65, 275–297.
2. Chiba, Y. and VanderWeele, T. J. (2011). A simple method for principal strata effects when the outcome has been truncated due to death. American Journal of Epidemiology 173, 745–751.
3. Cowles, M. K. and Carlin, B. P. (1996). Markov Chain Monte Carlo convergence diagnostics: A comparative review. Journal of the American Statistical Association 91, 883–904.
4. Daniels, M. and Hogan, J. (2008). Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis. Boca Raton, FL: CRC Press.
5. Diehr, P., Patrick, D. L., Spertus, J., Kiefe, C. I., Donell, M., and Fihn, S. D. (2001). Transforming self-rated health and the SF-36 scales to include death to improve interpretability. Medical Care 39, 670–680.
6. Frangakis, C. E. and Rubin, D. B. (2002). Principal stratification in causal inference. Biometrics 58, 21–29.
7. Hayden, D., Pauler, D. K., and Schoenfeld, D. (2005). An esitmator for treatment comparisons among survivors in randomized trials. Biometrics 61, 305–310.
8. Ibrahim, J. G., Chu, H., and Chen, L. M. (2010). Basic concepts and methods for joint models of longitudinal and survival data. Journal of Clinical Oncology 28, 2796–2801.
9. Joshua Chen, Y., Gould, A. L., and Nessly, M. L. (2005). Treatment comparisons for a partially categorical outcome applied to a biomarker with assay limit. Statistics in Medicine 24, 211–228.
10. Kurland, B. F. and Heagerty, P. J. (2005). Directly parameterized regression conditioning on being alive: Analysis of longitudinal data truncated by deaths. Biostatistics 6, 241–258.
11. Kurland, B. F., Johnson, L. L., Egleston, B. L., and Diehr, P. H. (2009). Longitudinal data with follow-up truncated by death: match the analysis method to research aims. Statistical Science 24, 211–222.
12. Lachin, J. M. (1999). Worst-rank score analysis with informatively missing observations in clinical trials. Controlled Clinical Trials 20, 408–422.
13. Little, R. J. (1993). Pattern-mixture models for multivariate incomplete data. Journal of the American Statistical Association 88, 125–134.
14. Little, R. J. (1994). A class of pattern-mixture models for normal incomplete data. Biometrika 81, 471–483.
15. Mann, H. B. and Whitney, D. R. (1947). On a test of whether one of two random variables is stochastically larger than the other. The Annals of Mathematical Statistics 18, 50–60.
16. Minini, P. and Chavance, M. (2004). Sensitivity analysis of longitudinal binary data with non-monotone missing values. Biostatistics 5, 531–544.
17. Muller, P. (1991). A generic approach to posterior integration and Gibbs sampling. Technical report, Purdue University.
18. National Research Council Panel on Handling Missing Data in Clinical Trials (2010). The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: The National Academies Press
19. Neal, R. M. (2003). Slice sampling. Annals of Statistics 31, 705–741.
20. Rizopoulos, D. (2012). Joint Models for Longitudinal and Time-to-Event Data: With Applications in R. Boca Raton, FL: CRC Press.
21. Robert, C. P. (1997). Discussion of Richardson and Green's paper. Journal of the Royal Statistical Society, Series B (Statistical Methodology) 59, 758–764.
22. Robins, J., Rotnitzky, A., and Scharfstein, D. (2000). Sensitivity analysis for selection bias and unmeasured confounding in missing data and causal inference models. In Statistical Models for Epidemiology, E. Halloran (eds), 1–94. New York: Springer-Verlag.
23. Robins, J. M. and Gill, R. D. (1997). Non-response models for the analysis of non-monotone ignorable missing data. Statistics in Medicine 16, 39–56.
24. Rosenbaum, P. R. (1984). The consequences of adjustment for a concomitant variable that has been affected by the treatment. Journal of the Royal Statistical Society, Series A 147, 656–666.
25. Rotnitzky, A., Robins, J., and Scharfstein, D. (1998). Semiparametric regression for repeated outcomes with non-ignorable non-response. Journal of the American Statistical Association 93, 1321–1339.
26. Rotnitzky, A., Scharfstein, D., Su, T., and Robins, J. (2001a). A sensitivity analysis methodology for randomized trials with potentially non-ignorable cause-specific censoring. Biometrics 57, 103–113.
27. Rotnitzky, A., Scharfstein, D., Su, T.-L., and Robins, J. (2001b). Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring. Biometrics 57, 103–113.
28. Scharfstein, D., Daniels, M., and Robins, J. (2003). Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing outcomes. Biostatistics 4, 495.
29. Scharfstein, D., McDermott, A., Olson, W., and F, W. (2014). Global sensitivity analysis for repeated measures studies with informative drop-out. Statistics in Biopharmaceutical Research 6, 338–348.
30. Scharfstein, D., Rotnitzky, A., and Robins, J. (1999). Adjusting for non-ignorable drop-out using semiparametric non-response models (with discussion). Journal of the American Statistical Association 94, 1096–1146.
31. Shardell, M. and Miller, R. R. (2008). Weighted estimating equations for longitudinal studies with death and non-monotone missing time-dependent covariates and outcomes. Statistics in Medicine 27, 1008–1025.
32. Temel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., et al. (2016). Anamorelin in patients with non-small-cell lung cancer and cachexia (romana 1 and romana 2): Results from two randomised, double-blind, phase 3 trials. The Lancet Oncology 17, 519–531.
33. Tsiatis, A. (2007). Semiparametric Theory and Missing Data. New York: Springer Science & Business Media.
34. Tsiatis, A. A. and Davidian, M. (2004). Joint modeling of longitudinal and time-to-event data: An overview. Statistica Sinica 14, 809–834.
35. Vansteelandt, S., Rotnitzky, A., and Robins, J. (2007). Estimation of regression models for the mean of repeated outcomes under nonignorable nonmonotone nonresponse. Biometrika 94, 841–860.
36. Wulfsohn, M. S. and Tsiatis, A. A. (1997). A joint model for survival and longitudinal data measured with error. Biometrics 53, 330–339.